CMC-544 (inotuzumab ozogamicin): A CD22-targeted immunoconjugate of calicheamicin. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2025 Aug. 7];2(5). Available from: https://journals.pagepress.org/hmr/article/view/735